Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
Más filtros










Intervalo de año de publicación
1.
J Fr Ophtalmol ; 47(4): 104138, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38484481

RESUMEN

PURPOSE: To present the clinical, genetic, and histopathological features of the ninth family affected by congenital stromal corneal dystrophy (CSCD) to date. METHODS: Twelve cases of a Spanish family affected by CSCD were analyzed regarding history, visual acuity (VA, decimal scale), an ophthalmologic exam and specular microscopy. Five eyes were treated by deep anterior lamellar keratoplasty (DALK), and thirteen eyes by penetrating keratoplasty (PK). In the two last generations, a genetic study was performed. RESULTS: Most of the patients affected were born with opaque corneas except for three, whose corneas were clear at birth. Biomicroscopy showed a whitish diffuse stromal opacity with an unaltered epithelium, causing poor VA (from hand motions to 0.4). Patients treated with PK presented mean postoperative VA of 0.19±0.20 over a follow-up time of 235.3±101.4months with 38% recurrences. Patients who underwent DALK experienced VA improvement to 0.17±0.11 over a follow-up time of 10.8±2.6months without signs of recurrence. In the latter, the big bubble technique was not achieved, so a manual technique was performed. The genetic study showed heterozygosis for a 1-bp deletion at nucleotide 962 in exon 8 of the decorin gene. CONCLUSIONS: CSCD is a rare entity, which should be treated by DALK whenever possible, obtaining better results than PK. Close monitoring of children of affected individuals is important, because CSCD can progress during the early years of life.


Asunto(s)
Distrofias Hereditarias de la Córnea , Trasplante de Córnea , Queratocono , Niño , Recién Nacido , Humanos , Trasplante de Córnea/métodos , Distrofias Hereditarias de la Córnea/diagnóstico , Distrofias Hereditarias de la Córnea/genética , Distrofias Hereditarias de la Córnea/patología , Queratoplastia Penetrante , Endotelio Corneal/patología , Estudios Retrospectivos , Resultado del Tratamiento , Queratocono/cirugía
2.
Neurología (Barc., Ed. impr.) ; 38(6): 387-390, Jul-Ago. 2023. tab, ilus
Artículo en Español | IBECS | ID: ibc-222260

RESUMEN

Introducción: La fotofobia es un síntoma de intolerancia anómala a la luz sin sensación de dolor que requiere de una anamnesis y una exploración para el diagnóstico de una etiología subyacente.Procedimiento básico: El presente artículo se centra en 30 casos clínicos con fotofobia intensa aislada y su revisión de la bibliografía. Objetivo: El objetivo consiste en establecer unos criterios diagnósticos de la fotofobia. Resultados: La etiología de la fotofobia parece encontrarse a nivel de las células ganglionares de la retina intrínsecamente fotosensibles, conocidas como las células de la melanopsina, y a un nivel neuroquímico mediado por el péptido relacionado con la calcitonina y el péptido pituitario activador de la ciclasa. Conclusión: El tratamiento de la fotofobia podría consistir en anticuerpos monoclonales contra los péptidos relacionados con la calcitonina y/o el péptido pituitario activador de la ciclasa.(AU)


Introduction: Photophobia is a symptom of abnormal light intolerance without pain sensation that requires an anamnesis and an examination to diagnose an underlying etiology. Basic procedure: This article focuses on 30 clinical cases with isolated intense photophobia and on the review of the literature. Objective: The purpose of this article is to establish diagnostic criteria for photophobia. Results: The etiology of photophobia appears to be at the level of the intrinsically photosensitive retinal ganglion cells known as melanopsin cells and at a neurochemical level mediated by calcitonin-related peptide and the pituitary activating peptide cyclase. Conclusion: The treatment of photophobia could consist of monoclonal antibodies against calcitonin-related peptide and/or pituitary activating peptide cyclase.(AU)


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Fotofobia/diagnóstico , Fotofobia/epidemiología , Fotofobia/etiología , Trastornos Migrañosos , Calcitonina , Anamnesis , Técnicas de Diagnóstico Oftalmológico , Examen Neurológico , Enfermedades del Sistema Nervioso , Oftalmología
3.
Neurologia (Engl Ed) ; 38(6): 387-390, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-35842130

RESUMEN

INTRODUCTION: Photophobia is a symptom of abnormal light intolerance without pain sensation that requires an anamnesis and an examination to diagnose an underlying etiology. BASIC PROCEDURE: This article focuses on 30 clinical cases with isolated intense photophobia and on the review of the literature. OBJECTIVE: The purpose of this article is to establish diagnostic criteria for photophobia. RESULTS: The etiology of photophobia appears to be at the level of the intrinsically photosensitive retinal ganglion cells known as melanopsin cells and at a neurochemical level mediated by calcitonin-related peptide and the pituitary activating peptide cyclase. CONCLUSION: The treatment of photophobia could consist of monoclonal antibodies against calcitonin-related peptide and/or pituitary activating peptide cyclase.


Asunto(s)
Trastornos Migrañosos , Fotofobia , Humanos , Fotofobia/etiología , Calcitonina , Trastornos Migrañosos/diagnóstico , Trastornos Migrañosos/complicaciones , Opsinas de Bastones , Células Ganglionares de la Retina
4.
Arch Soc Esp Oftalmol (Engl Ed) ; 97(1): 52-57, 2022 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-35027147

RESUMEN

We present the clinical case of a patient who developed a toxic optic neuropathy due to ethambutol in the context of a tuberculosis reactivation and who also had a personal history of multiple sclerosis. The objective is to highlight the importance of making a good differential diagnosis of this adverse effect and of knowing its main clinical, campimetric and tomographic manifestations and characteristics. Furthermore, since the reversibility of damage is still discussed in the literature, early diagnosis is essential. For this purpose, it is important to inform the patient of the possible symptoms and to carry out an ophthalmological examination and colour tests before starting treatment to assess whether there is progression.


Asunto(s)
Esclerosis Múltiple , Enfermedades del Nervio Óptico , Antituberculosos/efectos adversos , Etambutol/efectos adversos , Humanos , Nervio Óptico , Enfermedades del Nervio Óptico/inducido químicamente , Enfermedades del Nervio Óptico/diagnóstico
5.
Arch. Soc. Esp. Oftalmol ; 97(1): 52-57, ene.,2022. graf
Artículo en Español | IBECS | ID: ibc-202733

RESUMEN

Presentamos el caso clínico de una paciente que desarrolló una neuropatía óptica tóxica por etambutol en el contexto de una reactivación tuberculosa y que, además, presentaba como antecedentes personales una esclerosis múltiple. El objetivo es destacar la importancia de realizar un buen diagnóstico diferencial de este efecto adverso y de conocer sus manifestaciones y características clínicas, campimétricas y tomográficas principales. Además, dado que la reversibilidad del daño sigue siendo discutida en la bibliografía, es esencial el diagnóstico precoz para lo que es importante informar al paciente de los posibles síntomas, así como llevar a cabo una exploración oftalmológica y test cromáticos antes de comenzar el tratamiento para valorar si hay progresión.


We present the clinical case of a patient who developed a toxic optic neuropathy due to ethambutol in the context of a tuberculosis reactivation and who also had a personal history of multiple sclerosis. The objective is to highlight the importance of making a good differential diagnosis of this adverse effect and of knowing its main clinical, campimetric and tomographic manifestations and characteristics. Furthermore, since the reversibility of damage is still discussed in the literature, early diagnosis is essential. For this purpose, it is important to inform the patient of the possible symptoms and to carry out an ophthalmological examination and colour tests before starting treatment to assess whether there is progression.


Asunto(s)
Humanos , Ciencias de la Salud , Oftalmología , Enfermedades del Nervio Óptico , Etambutol/toxicidad , Esclerosis Múltiple , Tomografía de Coherencia Óptica
9.
Rev. andal. med. deporte ; 14(1): 24-27, mar. 2021. tab
Artículo en Español | IBECS | ID: ibc-200376

RESUMEN

OBJETIVO: Determinar las características clínicas y epidemiológicas de los traumatismos deportivos oculares de la población asistencial de un hospital terciario de Madrid. MÉTODO: Recopilación retrospectiva de los datos clínicos de los pacientes que acudieron al servicio de urgencias del Hospital Clínico San Carlos en el periodo enero 2015-diciembre 2017 y que habían sufrido un traumatismo ocular durante la práctica de algún deporte. RESULTADOS: Se incluyeron en el estudio un total de 54 pacientes. 47 (87.04%) fueron hombres. La edad media fue de 27.26 años ± 13.01 años de desviación estándar. El deporte que causó más traumatismos entre los pacientes incluidos en el estudio fue el fútbol, seguido de deportes de raqueta, fuerza y combate y baloncesto. La iritis traumática fue el diagnóstico más frecuente, seguido de lesión periocular, lesiones de polo anterior, conmoción retiniana, lesiones regmatógenas, fractura orbitaria y desprendimiento de retina. El 87.04% de los cuadros se resolvieron con tratamiento médico. CONCLUSIONES: La mayoría de los traumatismos oculares deportivos son leves y se resuelven apenas con tratamiento médico. Se deben excluir diagnósticos más graves que requieran de un tratamiento más específico. Las campañas de prevención de daños deben ir encaminadas a los grupos con mayor riesgo de presentarlos


OBJECTIVE: The purpose of this article is to determine the clinical and epidemiologic characteristics of ocular sports injuries in a tertiary hospital of Madrid. METHOD: The study was based on a retrospective record of clinical data of patients who underwent clinical exploration after ocular sport injury between January 2015 and December 2017 in Clinic Hospital San Carlos. RESULTS: A total of 54 patients were recruited from which 47 (87.04%) were males. The mean age was 27.26 years ± 13.01 years Standard Deviation. The sport with the most frequent cause of ocular injury was soccer, followed by racket sports, fight sports and basketball. Traumatic iritis was the most frequent diagnosis, followed by periocular lesions, anterior segment lesions, conmotio retinae, rhegmatogenous lesions, orbital fracture and retinal detachment. Medical treatment solved 87.04% of the cases. CONCLUSIONS: Most of the sports related to ocular injuries were minor cases and they could be solved with only medical treatment. More severe diagnosis must be investigated for more specific treatments, thought. Prevention strategies must be focused in higher risk groups


OBJETIVO: O objetivo deste artigo é determinar as características clínicas e epidemiológicas das lesões oculares desportivas num hospital terciário de Madrid. MÉTODO: O estudo foi baseado num registo retrospectivo de dados clínicos de doentes que foram submetidos a exploração clínica depois duma lesão desportiva ocular entre Janeiro de 2015 e Dezembro de 2017 no Hospital Clínico San Carlos. RESULTADOS: Foram recrutados 54 doentes, dos quais 47 (87.04%) eram do sexo masculino. A idade média foi de 27.26 anos ± 13.01 anos de desvio padrão. O desporto que mais frequentemente causou lesões oculares foi o futebol, seguido dos desportos de raquete, luta desportiva e basquetebol. A irite traumática foi o diagnóstico mais frequente, seguida de lesões perioculares, lesões do segmento anterior, conmotio retinae, lesões regmatogénicas, fractura orbital e descolamento da retina. O tratamento médico resolveu 87.04% dos casos. CONCLUSÕES: A maioria dos desportos relacionados com lesões oculares foram casos menores e só puderam ser resolvidos com tratamento médico. É necessário investigar um diagnóstico mais rigoroso para tratamentos mais específicos. As estratégias de prevenção devem ser centradas nos grupos de maior risco


Asunto(s)
Humanos , Masculino , Adolescente , Adulto Joven , Adulto , Traumatismos en Atletas/complicaciones , Traumatismos en Atletas/epidemiología , Lesiones Oculares/epidemiología , Lesiones Oculares/prevención & control , Estudios Retrospectivos , Deportes de Raqueta/estadística & datos numéricos , Fútbol/estadística & datos numéricos , Baloncesto/estadística & datos numéricos
10.
Artículo en Inglés, Español | MEDLINE | ID: mdl-33632567

RESUMEN

We present the clinical case of a patient who developed a toxic optic neuropathy due to ethambutol in the context of a tuberculosis reactivation and who also had a personal history of multiple sclerosis. The objective is to highlight the importance of making a good differential diagnosis of this adverse effect and of knowing its main clinical, campimetric and tomographic manifestations and characteristics. Furthermore, since the reversibility of damage is still discussed in the literature, early diagnosis is essential. For this purpose, it is important to inform the patient of the possible symptoms and to carry out an ophthalmological examination and colour tests before starting treatment to assess whether there is progression.

11.
Neurologia (Engl Ed) ; 2021 Feb 20.
Artículo en Inglés, Español | MEDLINE | ID: mdl-33622562

RESUMEN

INTRODUCTION: Photophobia is a symptom of abnormal light intolerance without pain sensation that requires an anamnesis and an examination to diagnose an underlying etiology. BASIC PROCEDURE: This article focuses on 30 clinical cases with isolated intense photophobia and on the review of the literature. OBJECTIVE: The purpose of this article is to establish diagnostic criteria for photophobia. RESULTS: The etiology of photophobia appears to be at the level of the intrinsically photosensitive retinal ganglion cells known as melanopsin cells and at a neurochemical level mediated by calcitonin-related peptide and the pituitary activating peptide cyclase. CONCLUSION: The treatment of photophobia could consist of monoclonal antibodies against calcitonin-related peptide and/or pituitary activating peptide cyclase.

18.
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...